Supports the natural removal process of forever chemicals from the body

99%

of people worldwide
have detectable levels of PFAS in the body
( ~ 14% of people have PFAS in the body above the health based guidance value )

6 million

annual deaths worldwide are linked to long-term health impacts of PFAS exposure

1 million

people get tested for PFAS levels in their body

We’ve found that certain gut bacteria interact with PFAS, which could help us understand new ways to reduce their presence in the body.

Kiran Raosaheb Patil

Professor of Molecular Systems Biology, University of Cambridge

What are PFAS?

Per-and polyfluoroalkyl substances (PFAS), often referred to as “forever chemicals,” are a large group of human-made compounds used for their water-resistant, oil-resistant, and nonstick properties. PFAS are extremely persistent in the environment and the human body, meaning they do not break down easily and unfortunately accumulate for decades.

How toxic are PFAS?

PFAS compounds can accumulate in nature, plants, animals, and humans.  According to the National Academy of Science, Engineering, and Medicine    (NASEM), PFAS levels above 2 ng/ml in human blood serum are considered to have potential adverse health effects. The global societal costs, including remediation and healthcare of PFAS chemicals, amount to ~18 trillion per year.

How are we exposed?

PFAS contamination affects various population segments in different ways. Workers in chemical manufacturing, firefighting, textile production, and industries producing nonstick or water- and stain-repellent materials face the highest risk. For the general population, PFAS exposure primarily occurs through consuming contaminated water and food, as well as using consumer products containing these substances.

PFAS Removal

Cambiotics introduces a precision-formulated probiotic that supports the body’s natural process for removal of forever chemicals. Its specialized probiotic strains are designed to interact with PFAS molecules in the gut and support their removal through the digestive system.

Test your PFAS levels

You can test your PFAS levels in the blood to manage the levels. This test is brought to you by our partner, Quest Diagnostics present in 2300 centers in United states.

Click here : PFAS BLOOD TEST

Contain probiotic strains that have been shown in scientific studies to bioaccumulate PFAS from their surroundings.

Sign up for the waiting list

Product available in United States in 2026

If you are based in Europe, Asia, or Africa, do not fill the form, please contact us at sales [at] cambiotics [dot] com

How many people are exposed to PFAS?

>99%

of people polluted with PFAS

45%

of US Tapwater contaminated with PFAS

9 PFAS

Proposed as hazardous constituents by EPA

The ‘forever chemicals’ in 99% of US population

Today, the family of compounds, commonly called PFAS or forever chemicals, is found not only in pots and pans but also in the blood of people around the world, including 99% of the US population. PFAS chemicals pollute water, do not break down, and remain in the environment and people for decades.


                            
Read the article
At least 45% of the nation’s tap water is estimated to have one or more types of PFAS

This Unites States Geological Survey or USGS research marks the first time anyone has tested for and compared PFAS in tap water from both private and government-regulated public water supplies on a broad scale throughout the country. Those data were used to model and estimate PFAS contamination nationwide. This USGS study can help members of the public to understand their risk of exposure and inform policy and management decisions regarding testing and treatment options for drinking water.

 

Read the article
Proposal to list nine per- and polyfluoroalkyl compounds as resource conservation and recovery act hazardous constituents

On February 8, 2024, EPA proposed changes to the Resource Conservation and Recovery Act regulations by adding nine particular per- and polyfluoroalkyl compounds, their salts, and their structural isomers, to its list of hazardous constituents in Title 40 of the Code of Federal Regulations Part 261 Appendix VIII. These nine PFAS are: Perfluorooctanoic acid, Perfluorooctanesulfonic acid, Perfluorobutanesulfonic acid, Hexafluoropropylene oxide-dimer acid, Perfluorononanoic acid, Perfluorohexanesulfonic acid, Perfluorodecanoic acid, Perfluorohexanoic acid and Perfluorobutanoic acid.


                            
Read the article
Slide Image
Slide Image
Slide Image

Research partners

Business partners

Beyond the data: Firefighters and PFAS exposure

Partnerships against PFAS

Cambiotics is committed to supporting first responders, including firefighters and military personnel, in managing PFAS exposure. We aim to develop solutions that assist the body’s natural processes in dealing with these persistent chemicals.

Testing PFAS in blood

Only 3-5% of firefighters get tested for PFAS levels, often due to the lack of a solution following the test.

Test your PFAS levels here :

PFAS BLOOD TEST

 

Partnership with Cambiotics

We value meaningful partnerships at every stage—from raising awareness about PFAS to testing and exploring potential solutions together.

Contact us:

sales[at]cambiotics[dot]com



Our Team

Peter Holme Jensen, Ph.D.

Peter Holme Jensen is the Chief Executive Officer and co-founder of Cambiotics. Peter holds a Ph.D. in biochemistry from the University of Copenhagen and is a serial entrepreneur with a passion for biomimicry, seeking answers to innovative solutions in nature. The process of innovation is essential to Peter Holme Jensen. “We cannot be sure how long it takes or even where we end up, but we can decide to be passionate about what we do and enjoy the process.” Peter Holme Jensen is also a board member of Aquaporin A/S and Innovation Fund Denmark. 

Peter Holme Jensen, Ph.D.

Chief Executive Officer and Co-founder

Anna E. Lindell, Ph.D.

Anna is a co-founder and co-inventor at Cambiotics, driven by a passion for translating science into real-world impact. Holding a Ph.D. in Toxicology from the University of Cambridge, she made the leap from academia to entrepreneurship to close the gap between cutting-edge research and practical health solutions. At Cambiotics, Anna leads efforts to address the growing challenge of PFAS exposure through innovative, microbiome-based strategies. Her work focuses on leveraging probiotic science to support human health and advance the frontiers of environmental toxicology.

Anna E. Lindell, Ph.D.

VP Technology and Co-founder

Hitheshi Rathod, M.Sc.

Hitheshi Rathod, Business Developer at Cambiotics, is driven by a simple but powerful belief: healthcare should be accessible, affordable, and rooted in innovation. With a background in medical biotechnology and business in healthcare innovation, Hitheshi has led efforts in market analysis, strategic partnerships, and digital communication. She thrives on transforming complex science into relatable stories that resonate with real people.

Hitheshi Rathod, M.Sc.

Business Developer

Steen Dannemann Andersen

Steen is an experienced C-level executive with over 30 years in biotechnology, nutrition, and microbiome industries. He has successfully led businesses in the global dietary supplement and OTC sectors, playing key roles in several successful company exits, including Chr. Hansen, Bifodan, and Deerland. Steen brings valuable expertise to our board as we continue to grow and innovate.

Steen Dannemann Andersen

Chairman of the Board

Prof. Kiran Patil, Ph.D.

Kiran is a researcher with a background in Chemical Engineering from the Indian Institute of Technology (Mumbai) and a Ph.D. in Systems Biology from the Technical University of Denmark (DTU). Kiran then joined the European Molecular Biology Laboratory (EMBL-Heidelberg) and later became Director of Research at the MRC Toxicology Unit in 2019, before being appointed Professor of Molecular Systems Biology in 2022. His research centers on understanding the complex metabolic networks in the gut microbiota, exploring how these networks affect drug efficacy, action, and toxicity. Using a combination of computational and experimental approaches, Kiran aims to uncover the role of the microbiome in mediating the effects of drugs and environmental contaminants like pesticides.

Prof. Kiran Patil, Ph.D.

Board member and Co-founder

Peter Holme Jensen, Ph.D.

Peter Holme Jensen is the Chief Executive Officer and co-founder of Cambiotics. Peter holds a Ph.D. in biochemistry from the University of Copenhagen and is a serial entrepreneur with a passion for biomimicry, seeking answers to innovative solutions in nature. The process of innovation is essential to Peter Holme Jensen. “We cannot be sure how long it takes or even where we end up, but we can decide to be passionate about what we do and enjoy the process.” Peter Holme Jensen is also a board member of Aquaporin A/S and Innovation Fund Denmark.

Peter Holme Jensen, Ph.D.

Board member and Co-founder

Jessica Marissen

Jessica brings extensive experience in microbiology, a sharp eye for detail, and a love for solving scientific puzzles. She’s both creative and methodical, making her the perfect fit for designing and structuring complex lab experiments as we continue advancing our precision probiotics for PFAS detoxification. When she’s not in the lab, Jessica enjoys gardening and spending time with her two dogs, bringing both curiosity and calm wherever she goes.

Jessica Marissen

Laboratory Technician

Nila Amado, M.Sc.

Nila is a creative and results-driven marketing & communications professional with a strong background in project and event management. She combines strategic thinking with hands-on execution to craft engaging content that amplifies brand identity and drives growth. Nila is experienced in coordinating cross-functional campaigns and delivering seamless experiences across digital platforms and is passionate about turning ideas into impactful stories that connect science, innovation, and people.

Nila Amado, M.Sc.

Digital Marketing Developer

Emilie Glad Bak, Ph.D.

Emilie Glad Bak is a Senior Scientist at Cambiotics, specializing in translational science and clinical trials for microbiome-based interventions. With experience across academia, pharma, and food biotech, she supports driving Cambiotics’ translational models and clinical study designs. Emilie works closely with internal teams and external CRO partners to generate rigorous, clinically relevant evidence for Cambiotics’ PFAS-focused innovations.

Emilie Glad Bak, Ph.D.

Senior Scientist

Media

Publications – Expert insights from the frontlines of PFAS research

Read the article

BBC

British Broadcasting Corporation, England

Scientists discover protection from PFAS chemicals

Image Copyright: MRC Toxicology Unit

Read the article

Fox News

Fox News Channel, US 

Gut microbes could be key to fighting toxic, long-lasting ‘forever chemicals,’ research says

Illustration Copyright: MRC Toxicology Unit

Read the article

The Guardian

The Manchester Guardian, England


Some gut microbes can absorb and help expel ‘forever chemicals’ from the body, research shows

Image Copyright: MRC Toxicology Unit

Researchers found certain species of human gut bacteria had a remarkably high capacity to soak up PFAS and store it in clumps inside their cells.

Harriet Heywood

BBC News, Cambridgeshire

Scientists at the University of Cambridge have identified that a natural “gut microbiome could play a helpful role in removing toxic PFAS chemicals from our body,” following a study on mice.

Pilar Arias

Fox News

Certain kinds of gut microbes absorb toxic Pfas “forever chemicals” and help expel them from the body via feces, new first-of-its-kind University of Cambridge research shows.

Tom Perkins

The Guardian


Our Technology

Extensive PFAS accumulation by human gut bacteria

Cambiotics now offers a precision-formulated probiotic developed to support the body’s natural processes. Its specialized probiotic strains are designed to interact with PFAS molecules in the gut, facilitating their removal through the digestive system.

Illustration Copyright: MRC Toxicology Unit

Using biology to remove chemicals from the body

The technology was developed from pioneering research by Dr. Anna Lindell, Cambiotics’ VP of Technology and co-founder, in collaboration with Professor Kiran Patil at the MRC Toxicology Unit, University of Cambridge.

“Our probiotic formulation is designed to support the body’s natural response to PFAS exposure by engaging with these compounds through physiological pathways.” — Dr. Anna E. Lindell

To learn more about our science, we invite you to explore our publication in nature microbiology, which presents evidence that specific probiotic strains can interact with PFAS molecules across a range of concentrations, from nanomolar to high micromolar levels.


Human gut bacteria bioaccumulate per- and polyfluoroalkyl substances

Lindell, A.E. et al. Human gut bacteria bioaccumulate per- and polyfluoroalkyl substances. Nat Microbiol 10, 1630–1647 (2025).

Contact Us

Please enable JavaScript in your browser to complete this form.
Legal
Shop